Naoki Morimoto

3PUBLICATIONS
45CO-AUTHORS
Social program evaluationPredictive and prognostic markersGastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 01, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study.

Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka

|Oct 05, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.

Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta

|Oct 06, 2020
Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection.

Yoshinari Takaoka, Kouichi Miura, Naoki Morimoto

Pageof 1